4 completed, 1 unknown. 5 Phase 2, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 5 | Completed 4, Unknown 1 |
| Phase 1 | 1 | Completed 1 |
Follow Nadolol: new trials by email Literature Review of Nadolol trials Research Report on Nadolol
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study of Clenbuterol (CST-103) Co-administered With Nadolol (CST-107) in Subjects With Neurodegenerative Disorders clenbuterol (CST-103), nadolol (CST-107), matching placebo - Mild Cognitive Impairment, Lewy Body Dementia, Parkinson's Disease Rapid Eye Movement Sleep Behavior Disorder, Parkinson's Disease Dementia | Phase 2 | Completed | CuraSen Therapeutics, Inc. | 41 | 2021-06-28 | 2024-12-02 |
| Efficacy and Safety of Βeta-adrenoceptor Inverse Agonist and Biased Ligand, Nadolol, In Smoking Cessation of Patients With Chronic Cough With or Without Airflow Obstruction Nadolol, Placebo - Smoking Cessation | Phase 2 | Completed | Invion, Inc. | 155 | 2014-03-01 | 2017-02-01 |
| Efficacy and Safety of Beta-adrenoceptor Inverse Agonist, Nadolol, in Mild Asthma Nadolol, Placebo - Mild Persistent Asthma, Uncomplicated | Phase 2 | Unknown | Invion, Inc. | 60 | 2013-03-01 | 2016-08-09 |
| Nadolol for Proliferating Infantile Hemangiomas Nadolol - Infantile Hemangioma | Phase 2 | Completed | The Hospital for Sick Children | 20 | 2009-11-01 | 2021-08-19 |
| Oral Nadolol for the Treatment of Adults With Mild Asthma nadolol - Asthma | Phase 1 / Phase 2 | Completed | Invion, Inc. | 10 | 2007-01-01 | 2016-05-11 |
Asthma (1) · Cognitive Dysfunction (1) · Hemangioma, Capillary (1) · Lewy Body Disease (1) · Smoking Cessation (1)
Invion, Inc. (3) · CuraSen Therapeutics, Inc. (1) · The Hospital for Sick Children (1)
United States (3) · Australia (1) · Canada (1) · New Zealand (1) · United Kingdom (1)
Elena Pope, MD (1) · Mario Castro, M.D. (1) · Nicola A Hanania, MD (1) · Nicola A. Hanania, MD, MS (1)